v3.25.1
Stockholders' Equity
3 Months Ended
Mar. 28, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ Equity
Equity Awards

The following table reflects the activity of RSAs and RSUs during the thirteen weeks ended March 28, 2025:
Time-basedPerformance-basedMarket-based
SharesWeighted Average
Grant Date Fair Value
SharesWeighted Average
Grant Date Fair Value
SharesWeighted Average
Grant Date Fair Value
Unvested at December 27, 2024483,284 $35.68 881,500 $34.79 303,036 $30.04 
Granted192,089 63.67 528,973 63.67 35,101 61.16 
Vested(158,796)34.80 (162,351)32.45 (162,351)29.12 
Forfeited(8,543)37.37 (149,880)33.52 — — 
Unvested at March 28, 2025508,034 $46.51 1,098,242 $49.22 175,786 $37.10 

The Company granted 756,163 RSAs and RSUs to its employees and directors at a weighted average grant date fair value of $63.55 during the thirteen weeks ended March 28, 2025. These awards are a mix of time-, market- and performance-based grants that generally vest over a range of periods up to five years. The Company recognized expense on its RSAs and RSUs totaling $4,121 and $3,590 during the thirteen weeks ended March 28, 2025 and March 29, 2024, respectively. No share-based compensation expense has been capitalized.

At March 28, 2025, the total unrecognized compensation cost for unvested RSAs and RSUs was $36,692 and the weighted-average remaining period was approximately 2.1 years. Of this total, $21,261 related to awards with time-based vesting provisions and $15,431 related to awards with performance- and market-based vesting provisions. At March 28, 2025, the weighted-average remaining period for time-based vesting and performance-based vesting RSAs and RSUs were approximately 1.9 years and 2.3 years, respectively.

Performance-Based Restricted Share Units

In February 2025, the Company’s Board of Directors approved a grant of a total of 541,375 performance-based restricted share units (“PSUs”) to certain of the Company’s officers and employees under the Company’s 2019 Omnibus Equity Incentive Plan. The PSUs, which have a four-year term from the date of grant, are subject to service and performance conditions and will only become vested and payable to the extent that a qualifying change in control occurs during the four-year period. The fair value of these awards was $16,056 at March 28, 2025, which was determined using a Monte Carlo simulation in order to model a range of possible future stock prices for the Company’s common stock. No share-based compensation expense has been recorded in fiscal 2025 for these PSUs.

Share Repurchase Program

In November 2023, the Company announced a two-year share repurchase program in an amount up to $100,000. The remaining share purchase authorization was $82,617 at March 28, 2025. The Company is not obligated to repurchase any specific number of shares and may suspend or discontinue the program at any time.